4015 Share Price Performance
ر.س149.80
-5.00 (-3.23%)
13.0% undervalued intrinsic discount
ر.س172.24
Fair Value
Price ر.س149.80
AnalystConsensusTarget ر.س172.24
Fair Valueر.س172.24
Share Pricen/a
Jamjoom Pharmaceuticals Factory Company Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 18 Fair Values set on narratives written by author
4015 Community Narratives
AN
Fair Value ر.س172.24 13.0% undervalued intrinsic discount
Rising MENA Demand And Vision 2030 Investments Will Redefine Markets
0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
Rising MENA Demand And Vision 2030 Investments Will Redefine Markets
Key Takeaways Diversification into new therapeutic areas, supported by product launches, business deals, and a robust pipeline, is expected to enhance long-term revenue growth and portfolio resilience. Regional market expansion, healthcare investments, and improved manufacturing efficiency provide strong foundations for sustainable demand, cost management, and profit margin improvement.Read more
0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
AN
ر.س172.24
13.0% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
13.5% p.a.
Profit Margin
31.04%
Future PE
30.83x
Share price in 2028
ر.س291.05
Recently Updated Narratives
AN
Rising MENA Demand And Vision 2030 Investments Will Redefine Markets
Fair Value: ر.س172.24 13.0% undervalued intrinsic discount
10 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Jamjoom Pharmaceuticals Factory Company Key Details
About 4015
- Founded
- 1994
- Employees
- n/a
- CEO
- WebsiteView website
Jamjoom Pharmaceuticals Factory Company, together with its subsidiaries, engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally. The company offers human medicines; nutraceuticals; antibiotics; general analgesics; medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, and ulcer and acidity; treatment of various skin infections and cancer diseases; and eye drops, and ointments and cosmeceuticals. It also provides ophthalmic solutions, dermatology products, cardiovascular health, consumer health, respiratory health, gastrointestinal health, endocrinology and diabetes care, central nervous system, and pain and inflammation pharmaceutical products. Jamjoom Pharmaceuticals Factory Company was founded in 1994 and is based in Jeddah, the Kingdom of Saudi Arabia.
